Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
AAM Welcomes CMS Tiers Rule For Generics
Follows Industry Criticism Of Generics Increasingly Being Placed On Higher-Cost Tiers
Dec 14 2022
•
By
Dave Wallace
The CMS’ proposed rule has been applauded by the AAM
(Shutterstock)
More from Regulation
More from Policy & Regulation